Lobsor Pharmaceuticals
Pre-clinicalThe Lecigon treatment circumvents many of the troubles seen in the advance stage, gastrointestinal dysfunction with erratic gastric emptying, the short half-life of levodopa and the narrowing of the therapeutic window, all this with a reduced levodopa dose.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
The Lecigon treatment circumvents many of the troubles seen in the advance stage, gastrointestinal dysfunction with erratic gastric emptying, the short half-life of levodopa and the narrowing of the therapeutic window, all this with a reduced levodopa dose.
Drug Delivery